Navigation Links
Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
Date:5/3/2013

PRINCETON, N.J., May 3, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today its financial results for the quarter ended March 31, 2013.

Soligenix's revenues for the quarter ended March 31, 2013 were $0.9 million as compared to $0.6 million for the first quarter of 2012. Revenues increased by $0.3 million related to reimbursable costs from the Company's four active government funded programs most notably its ThermoVax™ thermostability technology grant focused on a novel method of rendering aluminum salt adjuvanted vaccines stable at elevated temperatures. 

Soligenix's net (loss) for March 31, 2013 was $1.1 million, or $(0.10) per share, as compared to $1.4 million, or $(0.13) per share, for the first quarter ended March 31, 2012, representing a decreased loss of $0.3 million. The decreased loss is primarily related to increased government funded grant activity and an overall reduction in operating expenses. 

Research and development expenses for the quarter ended March 31, 2013 were $0.8 million as compared to $0.9 million for the same period in 2012.  General and administrative expenses for the quarter ended March 31, 2013 were $0.5 million, compared to $0.7 million for the same period in 2012. Overall operating decreased by $0.3 million primarily due to the Company's continued efforts to manage expenses.

As of March 31, 2013, the Company's cash position was $2.6 million.

Christopher J. Schaber , PhD, President and Chief Executive Officer of Soligenix stated, "We continue to make steady progress in both our BioTherapeutics and Vaccine/BioDefense business segments.  We have expanded our product pipeline through a worldwide excl
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
2. Soligenix to Present at World Vaccine Congress & Expo
3. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
4. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
5. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
6. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
7. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
8. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
9. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
10. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... ANGLETON, Texas, June 2, 2011 Benchmark Electronics, Inc. ... manufacturing provider, announced today that a product it helped ... Design Excellence Awards. The Avedro Vedera KXS ... Design Excellence Award in the Radiological and Electromechanical Devices ...
... June 2, 2011 Pharmacy Choice and Access Now ... pharmacists across the nation and Texas, committed to preserving ... of Senate Bill 7 (SB 7) in the current ... provide many necessary protections for Texans and their community ...
Cached Medicine Technology:Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category 2Pharmacy Choice and Access Now Coalition Urges Passage of Senate Bill 7 During Texas Legislature's Special Session 2
(Date:4/18/2014)... article published online in The Gerontologist ... music is associated with a decrease in anxiety about ... of control over their lives. In particular, listening to ... about death and an increase in sense of control. ... women and men, and individuals of both low- and ...
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at ... how blocking a particular molecule in metastatic breast cancer ... number of lung metastases. BRI scientists have found in ... shrink tumors by 60 - 80 percent and can ... lung. The $1.8 million five-year grant comes from the ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... Sept. 24 Speaker Nancy Pelosi,issued the following ... fiscal responsibility. Documents are available on the,Administration,s record ... to meeting our national priorities -- in a ... spending:, "The President has no credibility on ...
... Care for Urgent Health Problems Report Highest Satisfaction When ... Walk-in Clinics , Patient satisfaction with after-hours care for ... own family physician or their physicians after-hours clinic, compared ... health advisory services. According to a survey of 1,227 ...
... approximately 36,000 people in the United States, most over ... influenza vaccine in older seniors. Randomized, placebo-controlled clinical trials ... how well the vaccine can prevent death in this ... October issue of The Lancet Infectious Diseases, now available ...
... host more than 200 physicians and emergency medicine technicians ... Conference, Sept. 26-28. Those attending will learn how to ... circumstances encountered in the wilderness., The emergency medical system ... New York City and the 2005 Hurricane Katrina disaster ...
... Data Package Provided in NDA Demonstrates ... Once-Daily Tramadol Formulation, LAVAL, QC, Sept. 24 /PRNewswire-FirstCall/ ... is has requested a meeting with the U.S.,Food and ... for its once-daily formulation of tramadol. Based on,additional analysis ...
... Findings Raise Serious Concerns for Massive, Pending Carlyle Group Takeover ... ... on Carlyle to Ensure Buyout Doesn,t Worsen Care, WASHINGTON, Sept. 24 ... how cuts to staffing and,operations at nursing homes bought by private equity ...
Cached Medicine News:Health News:September/October 2007 Annals of Family Medicine tip sheet 2Health News:September/October 2007 Annals of Family Medicine tip sheet 3Health News:September/October 2007 Annals of Family Medicine tip sheet 4Health News:September/October 2007 Annals of Family Medicine tip sheet 5Health News:September/October 2007 Annals of Family Medicine tip sheet 6Health News:September/October 2007 Annals of Family Medicine tip sheet 7Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 2Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 3
Specimen-ID™, a Positive Specimen Identification System, assures the permanent link at the bedside between patient and laboratory specimen to prevent sample identification errors....
... The CAREt™ System is a ... state-of-the-art medication safety while improving ... assists in managing a myriad ... hand-held device linked real-time to ...
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
Medicine Products: